Charles River Laboratories Long Term Debt 2010-2024 | CRL

Charles River Laboratories long term debt from 2010 to 2024. Long term debt can be defined as the sum of all long term debt fields.
  • Charles River Laboratories long term debt for the quarter ending September 30, 2024 was $2.327B, a 7.46% decline year-over-year.
  • Charles River Laboratories long term debt for 2023 was $2.647B, a 2.23% decline from 2022.
  • Charles River Laboratories long term debt for 2022 was $2.708B, a 1.65% increase from 2021.
  • Charles River Laboratories long term debt for 2021 was $2.664B, a 38.04% increase from 2020.
Charles River Laboratories Annual Long Term Debt
(Millions of US $)
2023 $2,647
2022 $2,708
2021 $2,664
2020 $1,930
2019 $1,850
2018 $1,637
2017 $1,114
2016 $1,208
2015 $846
2014 $741
2013 $642
2012 $527
2011 $703
2010 $670
2009 $457
Charles River Laboratories Quarterly Long Term Debt
(Millions of US $)
2024-09-30 $2,327
2024-06-30 $2,409
2024-03-31 $2,660
2023-12-31 $2,647
2023-09-30 $2,514
2023-06-30 $2,678
2023-03-31 $2,744
2022-12-31 $2,708
2022-09-30 $2,937
2022-06-30 $2,997
2022-03-31 $2,676
2021-12-31 $2,664
2021-09-30 $2,893
2021-06-30 $2,727
2021-03-31 $2,202
2020-12-31 $1,930
2020-09-30 $1,968
2020-06-30 $2,207
2020-03-31 $2,327
2019-12-31 $1,850
2019-09-30 $1,883
2019-06-30 $2,040
2019-03-31 $1,541
2018-12-31 $1,637
2018-09-30 $1,653
2018-06-30 $1,796
2018-03-31 $1,130
2017-12-31 $1,114
2017-09-30 $1,156
2017-06-30 $1,116
2017-03-31 $1,170
2016-12-31 $1,208
2016-09-30 $1,233
2016-06-30 $1,331
2016-03-31 $840
2015-12-31 $846
2015-09-30 $836
2015-06-30 $755
2015-03-31 $755
2014-12-31 $741
2014-09-30 $755
2014-06-30 $782
2014-03-31 $614
2013-12-31 $642
2013-09-30 $624
2013-06-30 $620
2013-03-31 $518
2012-12-31 $527
2012-09-30 $543
2012-06-30 $551
2012-03-31 $675
2011-12-31 $703
2011-09-30 $720
2011-06-30 $731
2011-03-31 $761
2010-12-31 $670
2010-09-30 $701
2010-06-30 $409
2010-03-31 $438
2009-12-31 $457
2009-09-30 $464
2009-06-30 $486
2009-03-31 $474
Sector Industry Market Cap Revenue
Medical Medical Services $9.516B $4.129B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $91.424B 11.34
Cencora (COR) United States $47.484B 17.51
DiDi Global (DIDIY) China $23.330B 0.00
Natera (NTRA) United States $21.401B 0.00
ICON (ICLR) Ireland $16.136B 14.37
Viatris (VTRS) United States $15.576B 4.80
Avantor (AVTR) United States $13.422B 20.12
Revvity (RVTY) United States $13.376B 23.24
CochLear (CHEOY) Australia $12.844B 0.00
BioMerieux (BMXMF) France $12.666B 0.00
Solventum (SOLV) United States $11.583B 0.00
Medpace Holdings (MEDP) United States $9.789B 27.58
Doximity (DOCS) United States $9.620B 56.63
HealthEquity (HQY) United States $8.966B 48.66
Sonic Healthcare (SKHHY) Australia $8.758B 0.00
Bausch + Lomb (BLCO) Canada $6.885B 32.05
Life Times (LTH) United States $5.085B 33.66
Sotera Health (SHC) United States $3.855B 20.62
Organon (OGN) United States $3.757B 3.79
BrightSpring Health Services (BTSG) United States $3.247B 69.07
Surgery Partners (SGRY) United States $2.892B 32.97
PACS (PACS) United States $2.606B 0.00
Concentras Parent (CON) United States $2.581B 0.00
Ardent Health Partners (ARDT) United States $2.375B 0.00
Premier (PINC) United States $2.143B 11.15
Alignment Healthcare (ALHC) United States $2.126B 0.00
Ryman Healthcare (RYHTY) New Zealand $2.036B 0.00
GeneDx Holdings (WGS) United States $1.952B 0.00
GoodRx Holdings (GDRX) United States $1.616B 42.40
Teladoc Health (TDOC) United States $1.537B 0.00
Pediatrix Medical (MD) United States $1.255B 12.28
CareDx (CDNA) United States $1.183B 0.00
Progyny (PGNY) United States $1.164B 23.57
Establishment Labs Holdings (ESTA) $1.050B 0.00
AMN Healthcare Services Inc (AMN) United States $0.954B 6.46
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Embecta (EMBC) United States $0.778B 5.18
SBC Medicals (SBC) United States $0.677B 0.00
Agilon Health (AGL) United States $0.655B 0.00
InnovAge Holding (INNV) United States $0.647B 0.00
Auna S.A (AUNA) Luxembourg $0.536B 0.00
Sonida Senior Living (SNDA) United States $0.425B 0.00
DocGo (DCGO) United States $0.410B 15.46
Enhabit (EHAB) United States $0.366B 31.61
COMPASS Pathways (CMPS) United Kingdom $0.326B 0.00
LifeMD (LFMD) United States $0.241B 0.00
ModivCare (MODV) United States $0.223B 12.09
Sera Prognostics (SERA) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Biodesix (BDSX) United States $0.180B 0.00
Nutex Health (NUTX) United States $0.156B 0.00
Ascend Wellness Holdings (AAWH) United States $0.100B 0.00
So-Young (SY) China $0.092B 22.25
MultiPlan (MPLN) United States $0.084B 0.00
Singular Genomics Systems (OMIC) United States $0.054B 0.00
OncoCyte (OCX) United States $0.043B 0.00
NeueHealth (NEUE) United States $0.041B 1.08
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.030B 0.00
IceCure Medical (ICCM) Israel $0.028B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.020B 0.00
Oncology Institute (TOI) United States $0.014B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
KindlyMD (KDLY) United States $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00